Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Share-based Compensation (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Share-based Compensation for 2 consecutive years, with $8.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Share-based Compensation rose 671.21% to $8.7 million in Q4 2025 year-over-year; TTM through Oct 2025 was $36.0 million, a N/A change, with the full-year FY2025 number at $24.3 million, up 1531.05% from a year prior.
  • Share-based Compensation was $8.7 million for Q4 2025 at Kestra Medical Technologies, up from $4.6 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $22.7 million in Q2 2025 to a low of $37000.0 in Q1 2025.